Hikma Pharmaceuticals PLC HIK shares shed 3.16% to £19.02 Friday, on what proved to be an all-around rough trading session ...

Shares of Hikma Pharmaceuticals PLC HIK dropped 1.95% to £19.15 Tuesday, on what proved to be an all-around favorable trading ...

IBD is a chronic inflammation of the intestine characterised by severe stomach pain and diarrhoea affecting nearly 5 million people worldwide Riyadh – Hikma Pharmaceuticals KSA, announced the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables ...

In South Carolina’s Lowcountry, artists, farmers and designers are writing a new chapter in indigo’s rich and tangled history. By Patricia Leigh Brown In Brandon Ndife’s otherworldly ...

As a key investor in WLG, Debiopharm has consistently supported the company's innovative approaches and cutting-edge solutions through Debiopharm's Innovation Fund. This collaboration provides a ...

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law requiring pharmaceutical companies to negotiate drug prices with the ...

A Chinese design patent application goes through three stages: filing, preliminary examination and grant. It is granted after no grounds for rejection are found in the preliminary examination, and ...